Starting today, July 1, 2026, Medicare is launching the "GLP-1 Bridge" pilot program, offering eligible seniors nationwide access to weight-loss medications like Wegovy and Zepbound for a flat $50 monthly copay. This temporary demonstration bypasses standard Part D restrictions to provide immediate, affordable treatment for obesity and related health conditions for millions of older Americans through December 2027. What Happened: Medicare has officially entered a new era of
